Alaunos Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Alaunos Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Alaunos Therapeutics, Inc. Operating Lease, Payments for the quarter ending November 15, 2023 was $100K.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $400K, a 50% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $800K, a 38.5% decline from 2021.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.3M, a 30% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $400K -$400K -50% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $800K -$500K -38.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-07
2021 $1.3M +$300K +30% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-30
2020 $1M +$300K +42.9% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-01
2019 $700K Jan 1, 2019 Dec 31, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.